Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Ayık KafaAudio: English

Podcast description: centenarian genetics, aging drugs and biological age with Dr. Nir Barzilai

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

At a glance

Automatic summary · not editorially reviewed

According to the description, Dr. Nir Barzilai discusses protective genes in centenarians, growth hormone and IGF-1, metformin and other drugs aimed at aging biology, peptides, supplements and biological age testing. The description frames the goal as compressing illness, not living forever. [1]

  1. The description says Dr. Barzilai studies protective genes that may delay aging and age-related diseases in centenarians. [1]

  2. The description says growth hormone and IGF-1 may affect aging differently depending on biological age. [1]

  3. The description asks whether biological age tests really measure aging. [1]

Centenarians, protective genes and healthspan

The description says Dr. Barzilai studies protective genes that may delay aging and age-related diseases in centenarians. It asks why some people live beyond 100 despite smoking, being overweight and not following a perfect health routine, and says exceptional longevity is not just about diet, exercise or supplements. The description attributes these points to the podcast discussion; it gives no study numbers, participant counts or follow-up. [1]

Hormones, metformin and drugs targeting aging

The description says growth hormone and IGF-1 may affect aging differently depending on biological age, and that hormones affect aging differently after 50. It names metformin, GLP-1 drugs, SGLT2 inhibitors and other gerotherapeutics as possible ways to target aging biology rather than single diseases, and mentions the TAME trial on metformin and aging. It also covers MOTS-c and Humanin peptides and the risks of unregulated peptide injections. No results or effect sizes are reported. [1]

Supplements, oxygen therapy and biological age tests

The description lists longevity supplements, vitamin D, hyperbaric oxygen therapy, stem cells, rapamycin and biological age testing as topics, and asks whether biological age tests really measure aging. It also asks when targeting biological aging should start and whether human lifespan could reach 120. These are described as discussion topics, not as established benefits; the description reports no outcomes for any of them. [1]

Context & limits

This is only the video description; the video and transcript were not reviewed. It reports no study design, sample size, follow-up or results, and the topics are attributed to the podcast discussion.

Based on the creator’s description; the full video and transcript were not analyzed.

[1] What Do People Who Live Beyond 100 Do Differently?Genes,Healthspan and Aging |130 Dr.Nir Barzilai,MD
Quoted passages in the original language
protective genes that help delay aging
depending on our biological age
Can Biological Age Tests Really Measure Aging

About this video

Creator description · original textText language: English

In this 130th episode of Sober Head Podcast, Dr. Esra Çavuşoğlu, PhD welcomes Dr. Nir Barzilai, MD. Dr. Nir Barzilai is Professor of Medicine and Genetics at Albert Einstein College of Medicine and Director of the Institute for Geroscience. He is one of the leading scientists in the fields of the biology of aging and the genetics of human longevity. His research focuses on protective genes that help delay aging and age-related diseases in centenarians, and he is also the driving force behind the TAME trial, which investigates the effects of metformin on aging. What if everything we think we know about longevity is wrong? Why do some people live beyond 100 despite smoking, being overweight, and never following a perfect health routine? In this episode of Sober Head podcast, I'm joined by Dr. Nir Barzilai, a pioneer in geroscience and longevity research, whose groundbreaking studies of centenarians have revealed how protective genetic mechanisms may delay age-related diseases and extend healthspan. We explore why exceptional longevity isn't just about diet, exercise, or supplements, and how growth hormone and IGF-1 may have dramatically different effects on aging depending on our biological age. Dr. Barzilai also explains the potential of metformin, GLP-1 drugs, SGLT2 inhibitors, and other gerotherapeutics to target the biology of aging rather than individual diseases. We discuss the science behind MOTS-c and Humanin peptides, the risks of unregulated peptide injections, the truth about longevity supplements, and what the evidence actually says about hyperbaric oxygen therapy, stem cells, and biological age testing. Can we slow biological aging, delay chronic disease, and remain healthy well into our 90s and beyond? The ultimate goal of longevity science may not be to live forever, but to compress illness into the shortest possible period at the end of life. Join us for a fascinating discussion about the future of aging, preventive medicine, and the science of living longer and healthier. #EsraÇavuşoğlu #AyıkKafa #ElevatingLifeEvolvingHealth #Longevilab #NirBarziali Dr. Nir Barzilai, MD Website: https://einsteinmed.edu/faculty/484/nir-barzilai Special thanks to T.C. Istanbul Gedik University https://www.gedik.edu.tr/en/ 00:00-05:06 Introduction to Dr. Nir Barzilai. 05:06-10:02 Why Centenarians Stay Healthy Longer 10:02-13:54 Longevity Genes: Living Unhealthily and Still Living Beyond 100! 13:54-18:03 Growth Hormone and IGF-1: Can More Be Harmful? 18:03-20:32 Why Hormones Affect Aging Differently After 50 20:32-22:59 Biological Age and Preventing Age-Related Disease 22:59-29:21 Longevity Supplements, Vitamin D and Clinical Evidence 29:21-33:39 Metformin, GLP-1 and Drugs That Target Aging 33:39-40:23 MOTS-c and Humanin: Peptide Benefits and Risks 40:23-45:00 Longevity Clinics, Hyperbaric Oxygen and Rapamycin 45:00-50:45 The Limits of Human Lifespan: Can We Reach 120? 50:45-55:00 Dr. Barzilai's Longevity Routine and Intermittent Fasting 55:00-58:00 Can Biological Age Tests Really Measure Aging? 58:00-59:28 When Should We Start Targeting Biological Aging? 59:28-1:02:01 Why is Metformin So Important? 1:02:01-1:02:38 Wrap up. *About Ayık Kafa* Dr. Esra Çavuşoğlu, PhD, took her studies, starting from her personal treatment experiences and continuing with her clinical psychology education, to the next level by completing her PhD focused on Addiction. Dr. Esra in Ayık Kafa podcast discusses the world’s latest technologies, protocols, products and research in the fields of Biohacking and Longevity, while sharing first-hand information and experiences about the Disease of Addiction, as well as her latest academic studies. *About Dr. Esra Çavuşoğlu, PhD* Longevilab’s founder, Dr. Esra, is a United States and internationally trained clinical psychologist and a certified addiction therapist in New York. She served as International Development Advisor on the Yale University Faculty of Medicine Clinical Advisory Board. She is the founder and supervisor of Gaziantep Oya Bahadır Yüksel Rehabilitation Center, Dr. Esra is the designer and implementer of the Turkey Rehabilitation Model. Dr. Esra founded the Contemporary Addiction Studies Association (ÇABAÇAD) in order to combat Turkey’s growing addiction problem. DisclaimerThe information and statements on our YouTube Channel Sober-Head are not intended to guide individuals towards medical diagnosis and treatment.Please consult with your doctor for medical diagnostic and treatment procedures.The content is shared for informational purposes only, derived from scientific studies prepared by EMC Medya Yayıncılık Ticaret Ltd. Şti.’s researchers, consultants, and authors/scientists, as well as compilations from publicly available public.

Ayık Kafa · 63 min · Source published: 2026-10-15

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…